Milagrosa Lopez Riego

Dr. Milagrosa Lopez Riego

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2023 in Radiation and Environmental Biophysics
Verified
Journal Article
Open access
PDF file
MRMilagrosa Lopez Riego
Milagrosa Lopez Riego
MPMagdalena Płódowska
Magdalena Płódowska
MLMilena Lis-Zajęcka
Milena Lis-Zajęcka
KJKamila Jeziorska
Kamila Jeziorska
STSylwia Tetela
Sylwia Tetela
AWAndrzej Wojcik
Andrzej Wojcik
Candidate ionising radiation exposure biomarkers must be validated in humans exposed in vivo. Blood from patients undergoing positron emission tomography–computed tomography scan (PET-CT) and skeletal scintigraphy (scintigraphy) was drawn before (0 h) and after (2 h) the procedure for correlation analyses of the response of selected biomarkers with radiation dose and other available patient information. FDXR, CDKN1A, BBC3, GADD45A, XPC, and MDM2 expression was determined by qRT-PCR, DNA damage (γH2AX) by flow cytometry, and reactive oxygen species (ROS) levels by flow cytometry using the 2′, 7′—dichlorofluorescein diacetate test in peripheral blood mononuclear cells (PBMC). For ROS experiments, 0- and 2-h samples were additionally exposed to UVA to determine whether diagnostic irradiation conditioned the response to further oxidative insult. With some exceptions, radiological imaging induced weak γH2AX foci, ROS and gene expression fold changes, the latter with good coherence across genes within a patient. Diagnostic imaging did not influence oxidative stress in PBMC successively exposed to UVA. Correlation analyses with patient characteristics led to low correlation coefficient values. γH2AX fold change, which correlated positively with gene expression, presented a weak positive correlation with injected activity, indicating a radiation-induced subtle increase in DNA damage and subsequent activation of the DNA damage response pathway. The exposure discrimination potential of these biomarkers in the absence of control samples as frequently demanded in radiological emergencies, was assessed using raw data. These results suggest that the variability of the response in heterogeneous populations might complicate identifying individuals exposed to low radiation doses.

21 October 2024 in Radiation Medicine and Protection
Verified
Journal Article
Open access
TPTomas Palmqvist
Tomas Palmqvist
MRMilagrosa Lopez Riego
Milagrosa Lopez Riego
MBMartin Bucher
Martin Bucher
UOUrsula Oestreicher
Ursula Oestreicher
SPStefan Pojtinger
Stefan Pojtinger
AWAndrzej Wojcik
Andrzej Wojcik

15 December 2023 in Frontiers in Public Health
Verified
Journal Article
Open access
PAPamela Akuwudike
Pamela Akuwudike
MRMilagrosa Lopez Riego
Milagrosa Lopez Riego
MMMichal Marczyk
Michal Marczyk
ZKZuzana Kocibalova
Zuzana Kocibalova
FBFabian Brückner
Fabian Brückner
LLLovisa Lundholm
Lovisa Lundholm
Introduction: Experimental studies complement epidemiological data on the biological effects of low doses and dose rates of ionizing radiation and help in determining the dose and dose rate effectiveness factor.Methods: Human VH10 skin fibroblasts exposed to 25, 50, and 100 mGy of 137Cs gamma radiation at 1.6, 8, 12 mGy/h, and at a high dose rate of 23.4 Gy/h, were analyzed for radiation-induced short- and long-term effects. Two sample cohorts, i.e., discovery (n = 30) and validation (n = 12), were subjected to RNA sequencing. The pool of the results from those six experiments with shared conditions (1.6 mGy/h; 24 h), together with an earlier time point (0 h), constituted a third cohort (n = 12).Results: The 100 mGy-exposed cells at all abovementioned dose rates, harvested at 0/24 h and 21 days after exposure, showed no strong gene expression changes. DMXL2, involved in the regulation of the NOTCH signaling pathway, presented a consistent upregulation among both the discovery and validation cohorts, and was validated by qPCR. Gene set enrichment analysis revealed that the NOTCH pathway was upregulated in the pooled cohort (p = 0.76, normalized enrichment score (NES) = 0.86). Apart from upregulated apical junction and downregulated DNA repair, few pathways were consistently changed across exposed cohorts. Concurringly, cell viability assays, performed 1, 3, and 6 days post irradiation, and colony forming assay, seeded just after exposure, did not reveal any statistically significant early effects on cell growth or survival patterns. Tendencies of increased viability (day 6) and reduced colony size (day 21) were observed at 12 mGy/h and 23.4 Gy/min. Furthermore, no long-term changes were observed in cell growth curves generated up to 70 days after exposure.Discussion: In conclusion, low doses of gamma radiation given at low dose rates had no strong cytotoxic effects on radioresistant VH10 cells.

Verified
Journal Article
Open access
PDF file
PAPamela Chiaka Akuwudike
Pamela Chiaka Akuwudike
ATAdrianna Tartas
Adrianna Tartas
MRMilagrosa Lopez Riego
Milagrosa Lopez Riego
ITIuliana Toma-Dasu
Iuliana Toma-Dasu
AWAndrzej Wojcik
Andrzej Wojcik
LLLovisa Lundholm
Lovisa Lundholm
Predicting the risk of second malignant neoplasms is complicated by uncertainties regarding the shape of the dose–response relationship at high doses. Limited understanding of the competitive relationship between cell killing and the accumulation of DNA lesions at high doses, as well as the effects of other modulatory factors unique to radiation exposure during radiotherapy, such as dose heterogeneity across normal tissue and dose fractionation, contribute to these uncertainties. The aim of this study was to analyze the impact of fractionated irradiations on two cell systems, focusing on the endpoints relevant for cancer induction. To simulate the heterogeneous dose distribution across normal tissue during radiotherapy, exponentially growing VH10 fibroblasts and AHH-1 lymphoblasts were irradiated with 9 and 12 fractions (VH10) and 10 fractions (AHH-1) at 0.25, 0.5, 1, or 2 Gy per fraction. The effects on cell growth, cell survival, radiosensitivity and the accumulation of residual DNA damage lesions were analyzed as functions of dose per fraction and the total absorbed dose. Residual γH2AX foci and other DNA damage markers (micronuclei, nuclear buds, and giant nuclei) were accumulated at high doses in both cell types, but in a cell type-dependent manner. The competitive relationship between cell killing and the accumulation of carcinogenic DNA damage following multifractional radiation exposure is cell type-specific.

5 May 2023 in Research Square
Verified
Preprint
Open access
PDF file
MRMilagrosa Lopez Riego
Milagrosa Lopez Riego
MPMagdalena Płódowska
Magdalena Płódowska
MLMilena Lis-Zajęcka
Milena Lis-Zajęcka
KJKamila Jeziorska
Kamila Jeziorska
STSylwia Tetela
Sylwia Tetela
AWAndrzej Wojcik
Andrzej Wojcik
Candidate ionising radiation exposure biomarkers must be validated in humans exposed in vivo. Blood from patients undergoing positron emission tomography - computed tomography scan (PET-CT) and skeletal scintigraphy (scintigraphy) was drawn before (0 h) and after (2 h) the procedure for correlation analyses of response of selected biomarkers with radiation dose and other available patient information. FDXR, CDKN1A, BBC3, GADD45A, XPCand MDM2 expression was determined by qRT-PCR, DNA damage (γH2AX) by flow cytometry, and reactive oxygen species (ROS) levels by flow cytometry using the 2', 7' – Dichlorofluorescin diacetate test in peripheral blood mononuclear cells (PBMC). For ROS experiments, 0- and 2 h samples were additionally exposed to UVA to determine whether diagnostic irradiation conditioned the response to further oxidative insult. With some exceptions, radiological imaging induced weak γH2AX foci, ROS and gene expression fold changes, the latter with good coherence across genes within a patient. Diagnostic imaging did not influence oxidative stress in PBMC successively exposed to UVA. Correlation analyses with patient characteristics led to low correlation coefficient values. γH2AX fold change, which correlated positively with gene expression, presented a weak positive correlation with injected activity, indicating a radiation-induced subtle increase in DNA damage and subsequent activation of the DNA damage response pathway. The exposure discrimination potential of these biomarkers in the absence of control samples, as frequently demanded in radiological emergencies, was assessed using raw data. These results suggest that the variability of the response in heterogeneous populations might complicate identifying individuals exposed to low radiation doses.

21 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
ACAleksandra Czyzak
Aleksandra Czyzak
GOGrainne O'Brien
Grainne O'Brien
MRMilagrosa Lopez Riego
Milagrosa Lopez Riego
LCLourdes Cruz-Garcia
Lourdes Cruz-Garcia
Christophe BadieChristophe Badie
Christophe Badie
Acute myeloid leukaemia (AML) remains a highly lethal malignancy with poor prognosis in adults above 60 years old, and often occurs after radiation exposure. Emerging evidence suggests that circadian rhythm disruption, prevalent in shift workers, may contribute to cancer development. Clock Genes (CGs) regulate fundamental cellular processes, including the DNA damage response (DDR), cell cycle progression, and haematopoiesis. This review examines the pathways linking circadian clock dysregulation to radiation-induced AML (rAML) and evaluates how temporal disruption may modulate leukemogenesis and radiation-induced effects. The evidence was synthesised on core clock components (BMAL1, CLOCK, PER, CRY, REV-ERB, ROR), their dysregulation in AML, and their roles in radiation response. Epigenetic and post-transcriptional regulatory mechanisms, including m⁶A RNA modification and sirtuin-mediated chromatin remodelling, were evaluated for their contribution to circadian-regulated DNA repair capacity. Multiple CGs demonstrated aberrant expression in AML, with BMAL1 showing tissue-specific dysregulation and PER1/2/3 consistently downregulated in peripheral blood. Clock proteins directly regulate DNA damage checkpoints through interactions with ATM/CHK2 and p53 pathways. Circadian disruption enhances inflammatory signalling, promotes accumulation of myeloid-derived suppressor cells, and accelerates immune senescence. Moreover, radiation exposure modulates CGs expression,which may alter repair fidelity and increase the leukemogenic risk. Understanding these connections in the context of disrupted circadian rhythm, could help identify at-risk populations, and improve shift workplace health policies.